Nifty

:

14823.15

Sensex

:

49206.47

98.35 (0.67%)
256.71 (0.52%)

Login

Nifty
Sensex

:
:

14823.15
49206.47

98.35 (0.67%)
256.71 (0.52%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

58/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

5338.65

07-May-2021

Open
High
Low
Previous Close

5330.00
5400.00
5311.85
5326.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

92355
4944.16
5900.00
3930.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,386.97
48.77
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

22,169.60
6.19%
10.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.56
1.35
3.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.84
5.76
2.73

PAT CAGR (%)

10 Years
5 Years
3 Years

8.44
10.79
12.24

P:E (Median)

8 Years
5 Years
3 Years

34.04
33.98
36.03

P:BV (Average)

8 Years
5 Years
3 Years

7.80
7.80
7.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.65
18.47
20.69

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 593.49 538.18 10.28% 595.41 567.06 5.00% 514.89 544.40 -5.42% 502.01 535.66 -6.28%
Expenses 396.72 404.74 -1.98% 392.09 402.88 -2.68% 328.60 378.17 -13.11% 393.30 384.67 2.24%
EBITDA 196.77 133.44 47.46% 203.32 164.18 23.84% 186.29 166.23 12.07% 108.71 150.99 -28.00%
EBIDTM 33.15% 24.79% 34.15% 28.95% 36.18% 30.53% -0.29% 28.19%
Other Income 14.57 58.22 -74.97% 12.15 44.75 -72.85% 17.20 35.83 -52.00% 45.22 35.45 27.56%
Interest 3.85 2.46 56.50% 4.71 2.62 79.77% 3.01 2.15 40.00% 3.62 0.61 493.44%
Depreciation 27.23 24.70 10.24% 27.73 25.13 10.35% 27.14 25.00 8.56% 28.41 17.61 61.33%
PBT 180.26 164.50 9.58% 183.03 181.18 1.02% 173.34 174.91 -0.90% 121.90 168.22 -27.54%
Tax 39.02 25.44 53.38% 51.66 26.93 91.83% 48.89 62.10 -21.27% 18.89 58.75 -67.85%
PAT 141.24 139.06 1.57% 131.37 154.25 -14.83% 124.45 112.81 10.32% 103.01 109.47 -5.90%
PATM 23.80% 25.84% 22.06% 27.20% 24.17% 20.72% 2.87% 20.44%
EPS 30.91 30.43 1.58% 28.75 33.75 -14.81% 27.23 24.68 10.33% 22.54 23.95 -5.89%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 2,205.80 2,151.65 2,081.50 1,968.51 1,966.26 2,012.34 1,853.32 1,111.81 1,048.84 1,093.29 1,252.45 Net Sales Growth 0.94% 3.37% 5.74% 0.11% -2.29% 8.58% 66.69% 6.00% -4.07% -12.71% Cost Of Goods Sold 1,101.09 741.69 678.48 677.55 711.67 698.85 649.77 305.51 270.02 290.09 312.64 Gross Profit 1,104.71 1,409.96 1,403.02 1,290.96 1,254.59 1,313.49 1,203.55 806.30 778.83 803.19 939.81 GP Margin 50.08% 65.53% 67.40% 65.58% 63.81% 65.27% 64.94% 72.52% 74.26% 73.47% 75.04% Total Expenditure 1,510.71 1,578.93 1,515.87 1,467.87 1,616.13 1,579.46 1,473.98 872.54 864.68 896.48 983.24 Power & Fuel Cost - 11.04 11.45 12.34 10.34 10.43 10.40 8.62 8.61 9.07 9.14 % Of Sales - 0.51% 0.55% 0.63% 0.53% 0.52% 0.56% 0.78% 0.82% 0.83% 0.73% Employee Cost - 364.51 323.84 314.29 303.89 277.34 236.36 191.77 211.12 192.82 226.99 % Of Sales - 16.94% 15.56% 15.97% 15.46% 13.78% 12.75% 17.25% 20.13% 17.64% 18.12% Manufacturing Exp. - 104.97 131.96 118.74 151.54 153.84 162.31 124.18 118.58 125.03 149.51 % Of Sales - 4.88% 6.34% 6.03% 7.71% 7.64% 8.76% 11.17% 11.31% 11.44% 11.94% General & Admin Exp. - 165.96 182.49 173.38 234.11 207.63 202.62 124.64 126.94 127.91 109.55 % Of Sales - 7.71% 8.77% 8.81% 11.91% 10.32% 10.93% 11.21% 12.10% 11.70% 8.75% Selling & Distn. Exp. - 153.70 152.83 143.35 152.82 168.00 156.82 87.83 100.10 122.93 113.34 % Of Sales - 7.14% 7.34% 7.28% 7.77% 8.35% 8.46% 7.90% 9.54% 11.24% 9.05% Miscellaneous Exp. - 37.06 34.82 28.22 51.76 63.38 55.71 29.98 29.32 28.62 113.34 % Of Sales - 1.72% 1.67% 1.43% 2.63% 3.15% 3.01% 2.70% 2.80% 2.62% 4.96% EBITDA 695.09 572.72 565.63 500.64 350.13 432.88 379.34 239.27 184.16 196.81 269.21 EBITDA Margin 31.51% 26.62% 27.17% 25.43% 17.81% 21.51% 20.47% 21.52% 17.56% 18.00% 21.49% Other Income 89.14 184.02 167.39 114.29 101.16 86.99 71.72 109.38 105.24 92.73 92.90 Interest 15.19 11.01 1.72 0.77 1.96 1.40 1.51 1.10 1.73 2.08 2.47 Depreciation 110.51 103.24 71.39 66.25 62.93 57.93 131.08 7.97 8.02 9.56 12.00 PBT 658.53 642.49 659.91 547.91 386.40 460.54 318.46 339.58 279.65 277.90 347.65 Tax 158.46 133.36 230.86 187.84 180.05 165.44 137.68 118.73 190.57 92.92 118.28 Tax Rate 24.06% 20.76% 34.98% 34.28% 34.84% 35.17% 66.36% 34.96% 27.47% 33.48% 34.32% PAT 500.07 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 226.34 PAT before Minority Interest 500.07 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 226.34 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.67% 23.66% 20.61% 18.29% 17.13% 15.16% 3.77% 19.86% 47.98% 16.89% 18.07% PAT Growth -3.01% 18.66% 19.16% 6.92% 10.43% 336.81% -68.39% -56.11% 172.57% -18.44% EPS 109.42 111.41 93.88 78.79 73.69 66.74 15.28 48.33 110.11 40.40 49.53

Description TTM Nov 08 Nov 07 Nov 06 Nov 05
Net Sales - 736.83 736.57 736.33 674.84 Net Sales Growth - 0.04% 0.03% 9.11% Cost Of Goods Sold - 195.94 190.88 186.99 189.67 Gross Profit - 540.89 545.69 549.34 485.17 GP Margin - 73.41% 74.09% 74.61% 71.89% Total Expenditure - 585.58 580.08 570.64 558.84 Power & Fuel Cost - 7.17 7.94 7.50 7.96 % Of Sales - 0.97% 1.08% 1.02% 1.18% Employee Cost - 98.43 98.71 100.37 98.57 % Of Sales - 13.36% 13.40% 13.63% 14.61% Manufacturing Exp. - 92.14 85.84 85.45 80.87 % Of Sales - 12.50% 11.65% 11.60% 11.98% General & Admin Exp. - 49.05 48.30 45.81 45.04 % Of Sales - 6.66% 6.56% 6.22% 6.67% Selling & Distn. Exp. - 99.87 106.89 103.95 96.59 % Of Sales - 13.55% 14.51% 14.12% 14.31% Miscellaneous Exp. - 42.98 41.51 40.57 40.15 % Of Sales - 5.83% 5.64% 5.51% 5.95% EBITDA - 151.25 156.49 165.69 116.00 EBITDA Margin - 20.53% 21.25% 22.50% 17.19% Other Income - 71.10 321.80 33.47 33.24 Interest - 0.00 0.02 0.07 0.16 Depreciation - 11.12 9.58 13.07 13.85 PBT - 211.22 468.69 186.01 135.23 Tax - 119.56 111.34 56.31 41.13 Tax Rate - 28.53% 24.67% 34.62% 36.77% PAT - 299.57 340.00 106.33 70.73 PAT before Minority Interest - 299.57 340.00 106.33 70.73 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 40.66% 46.16% 14.44% 10.48% PAT Growth - -11.89% 219.76% 50.33% EPS - 65.55 74.40 23.27 15.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,395.49 3,011.34 2,683.20 2,418.88 2,163.50 1,973.01 658.41 1,694.42 1,304.70 1,163.45 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 29.84 29.84 29.84 29.84 Total Reserves 3,349.74 2,965.59 2,637.45 2,373.13 2,117.75 1,927.26 628.57 1,664.58 1,274.85 1,133.60 Non-Current Liabilities 135.93 36.96 52.32 62.41 66.14 -34.97 -19.30 -25.71 -11.26 -0.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 2.50 2.50 0.00 0.00 0.00 0.00 Long Term Provisions 47.87 34.73 37.74 44.85 35.30 29.56 14.79 14.07 25.83 28.20 Current Liabilities 873.36 891.69 954.44 779.67 658.41 608.52 303.38 350.91 251.04 188.23 Trade Payables 426.78 435.92 495.63 388.00 337.92 334.20 159.93 150.59 136.04 98.03 Other Current Liabilities 340.37 294.19 302.29 241.36 181.52 80.59 54.68 39.56 35.64 42.78 Short Term Borrowings 2.50 2.50 2.50 2.50 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 103.71 159.08 154.02 147.81 138.97 193.72 88.76 160.76 79.36 47.42 Total Liabilities 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.56 942.49 2,019.62 1,544.48 1,350.72 Net Block 941.91 853.86 916.60 867.08 924.86 944.34 20.02 25.57 31.49 35.89 Gross Block 1,277.00 1,100.27 1,094.86 983.27 980.63 1,288.60 114.83 117.27 118.00 117.69 Accumulated Depreciation 335.09 246.41 178.26 116.19 55.77 344.26 94.81 91.71 86.51 81.81 Non Current Assets 1,356.53 1,224.63 1,273.24 1,209.65 1,255.58 1,294.53 256.54 215.24 213.67 179.20 Capital Work in Progress 0.76 0.00 1.04 15.35 3.27 12.56 3.16 0.37 0.38 1.64 Non Current Investment 30.95 32.33 33.72 35.11 36.51 42.66 44.49 45.99 47.50 48.95 Long Term Loans & Adv. 255.26 225.11 236.25 226.29 225.71 294.97 188.87 143.31 134.31 92.72 Other Non Current Assets 127.65 113.33 85.63 65.82 65.23 0.00 0.00 0.00 0.00 0.00 Current Assets 3,048.25 2,715.36 2,416.72 2,051.31 1,632.47 1,252.02 685.95 1,804.39 1,330.80 1,171.51 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 Inventories 430.59 386.66 297.06 321.90 360.68 387.90 151.50 165.15 183.24 159.32 Sundry Debtors 172.03 171.66 154.80 110.32 142.30 160.02 173.39 142.09 141.78 100.17 Cash & Bank 2,219.87 1,914.34 1,771.86 1,523.09 1,024.65 609.29 307.79 1,432.94 866.27 578.46 Other Current Assets 225.76 212.90 147.04 43.52 104.85 94.82 53.28 64.21 139.47 333.56 Short Term Loans & Adv. 25.82 29.80 45.96 52.48 57.20 80.52 47.17 43.23 129.83 325.23 Net Current Assets 2,174.89 1,823.67 1,462.28 1,271.64 974.06 643.51 382.58 1,453.47 1,079.77 983.28 Total Assets 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.55 942.49 2,019.63 1,544.47 1,350.71

Description Nov 08 Nov 07 Nov 06 Nov 05
Shareholder's Funds 901.09 649.72 439.76 375.95 Share Capital 29.84 29.84 29.84 29.84 Total Reserves 871.25 619.88 409.91 346.11 Non-Current Liabilities -22.67 -12.98 -14.36 -9.03 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 Current Liabilities 926.36 820.65 696.33 623.95 Trade Payables 108.18 92.43 137.62 120.16 Other Current Liabilities 14.50 14.17 8.14 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 Short Term Provisions 803.68 714.05 550.57 487.53 Total Liabilities 1,804.78 1,457.39 1,121.73 990.87 Net Block 50.76 60.16 69.96 75.56 Gross Block 139.90 141.61 168.14 170.15 Accumulated Depreciation 89.14 81.45 98.19 94.59 Non Current Assets 83.56 70.91 71.56 77.71 Capital Work in Progress 32.30 10.24 1.60 2.14 Non Current Investment 0.50 0.50 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 1,721.22 1,383.55 1,036.82 876.46 Current Investments 0.00 0.00 0.00 0.00 Inventories 124.99 95.85 99.31 90.71 Sundry Debtors 60.31 61.69 70.10 83.54 Cash & Bank 543.65 479.91 306.94 210.15 Other Current Assets 992.26 8.17 4.22 2.14 Short Term Loans & Adv. 977.77 737.92 556.25 489.92 Net Current Assets 794.86 562.90 340.50 252.52 Total Assets 1,804.78 1,457.39 1,121.72 990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 323.18 97.81 331.80 328.82 345.48 113.47 132.45 -16.01 24.46 80.14 PBT 642.49 659.91 547.91 516.83 470.42 238.02 339.58 279.65 277.90 347.65 Adjustment -53.56 -79.47 -32.98 -153.93 -19.53 60.89 -87.82 -84.49 -69.40 -65.23 Changes in Working Capital -52.46 -245.07 10.48 148.91 68.61 -40.42 4.62 -2.91 -61.86 -50.26 Cash after chg. in Working capital 536.47 335.37 525.41 511.81 519.51 258.48 256.39 192.25 146.65 232.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -213.29 -237.56 -193.61 -182.99 -174.03 -145.01 -123.94 -208.26 -121.81 -148.99 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -3.03 Cash From Investing Activity 1,530.32 35.12 -238.31 -249.64 -700.87 -88.77 102.66 625.87 277.52 57.14 Net Fixed Assets -177.49 -4.37 -97.28 -14.72 317.26 -1,183.17 -0.35 0.74 0.95 69.28 Net Investments 1.38 1.39 1.39 1.40 6.15 1.83 1.50 1.56 1.40 -48.45 Others 1,706.43 38.10 -142.42 -236.32 -1,024.28 1,092.57 101.51 623.57 275.17 36.31 Cash from Financing Activity -163.52 -109.85 -110.35 -82.59 -61.88 -1.38 -1,360.17 -43.20 -14.13 -86.26 Net Cash Inflow / Outflow 1,689.98 23.08 -16.86 -3.41 -417.27 23.32 -1,125.06 566.66 287.85 51.01 Opening Cash & Equivalents 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 578.42 527.40 Closing Cash & Equivalent 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 578.42

Description Nov 08 Nov 07 Nov 06 Nov 05
Cash From Operating Activity 237.76 16.63 123.19 102.74 PBT 211.22 468.69 186.01 135.23 Adjustment -49.50 -298.40 -8.73 7.24 Changes in Working Capital -7.89 -33.39 11.64 -2.41 Cash after chg. in Working capital 153.83 136.91 188.92 140.06 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -126.90 -113.33 -65.74 -37.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -78.87 232.35 -47.99 -73.08 Net Fixed Assets -20.35 17.89 2.55 Net Investments 0.00 -0.50 0.00 Others -58.52 214.96 -50.54 Cash from Financing Activity -95.20 -75.90 -33.82 -46.02 Net Cash Inflow / Outflow 63.69 173.09 41.38 -16.36 Opening Cash & Equivalents 479.91 306.83 10.00 26.36 Closing Cash & Equivalent 543.61 479.91 51.38 10.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 742.18 658.22 586.49 528.72 472.92 431.28 220.64 567.81 437.21 389.88 ROA 12.20% 11.25% 10.36% 10.95% 11.22% 4.00% 14.91% 28.24% 12.75% 13.40% ROE 15.89% 15.07% 14.11% 14.70% 14.75% 5.31% 18.77% 33.56% 14.96% 20.98% ROCE 20.38% 23.22% 21.49% 22.62% 22.78% 15.87% 28.96% 46.38% 22.66% 32.17% Fixed Asset Turnover 1.81 1.90 1.91 2.08 1.85 2.75 10.04 9.32 9.63 8.50 Receivable days 29.15 28.62 24.43 22.58 26.35 31.59 49.42 47.27 38.93 23.14 Inventory Days 69.32 59.95 57.05 61.01 65.25 51.10 49.61 58.01 55.11 38.34 Payable days 102.95 115.62 121.93 93.70 92.76 62.95 78.13 72.79 55.37 45.61 Cash Conversion Cycle -4.48 -27.05 -40.45 -10.12 -1.16 19.73 20.89 32.50 38.68 15.87 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 59.36 384.67 712.57 264.69 337.93 138.46 310.56 401.51 134.63 140.75

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

aditya birla sun life trustee private limited a/c aditya birla sun life equity hybrid '95 fund

life insurance corporation of india

qualified institutional buyers

Annual Reports:

News Update:

Pfizer decides to withdraw emergency use authorisation application in India
5th Feb 2021, 12:41 PM

Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback